Zoster-063
Research payments
$154,037
Through program year 2019, $154,037 in research payments was reported against Zoster-063, across 19 payments, paid by GlaxoSmithKline, LLC..
- Paid by
- GlaxoSmithKline, LLC.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2019 | Research | $154,037 | 19 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Kenneth Schmader Durham, NC Named on 4 payments
- Nicola Klein Oakland, CA Named on 4 payments
- Mary Beth Manning Cleveland, OH Named on 3 payments
- Max Nevarez Colorado Spgs, CO Named on 2 payments
- Kari Uusinarkaus Colorado Spgs, CO Named on 2 payments
- Myron Levin Aurora, CO Named on 1 payment
- Paul Hartley Uniontown, PA Named on 1 payment
- Victor Vidals Kansas City, MO Named on 1 payment
- Charles Fogarty Spartanburg, SC Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.